Spexis AG / Key word(s): Temporary Suspension04-Jun-2024 / 20:00 CET/CESTRelease of an ad hoc announcement pursuant to Art. 53 LRThe issuer is solely responsible for the content of this announcement.Ad hoc announcement pursuant to Art. 53 LRAllschwil, Switzerland, June 4, 2024Spexis launches appeal against SIX Excha.
Spexis receives second extension for the publication of its 2023 annual report until July 31, 2024, pharmiweb.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pharmiweb.com Daily Mail and Mail on Sunday newspapers.
Data from the PRECISION study of aprocitentan to be presented at the European Society of Hypertension Annual Meeting 2024 marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.
GNW-Adhoc: Data from the PRECISION study of aprocitentan to be presented at the European Society of Hypertension Annual Meeting 2024 () | aktiencheck.de